Atlas Trials

Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation

Clinical trial NCT01522651 · COMPLETED

Trial details

NCT number
NCT01522651
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2012-01-24
Primary completion
2014-03-10
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.